25%
ISCHEMIC STROKES ARE OF UNKNOWN CAUSE14
EXPLORE PFO SOLUTIONS
AMPLATZER™ TALISMAN™ PFO OCCLUSION SYSTEM
Stroke Risk Reduction
The Amplatzer™ Talisman™ PFO Occlusion System is built…
DATA FROM THE U.S. REVEALED THAT THE INITIAL LENGTH OF STAY WAS AN AVERAGE OF 4.4 DAYS SHORTER
for patients treated with TAVI compared to SAVR. TAVI also reduced the need for…
BETTER THERAPIES
We’re leading the way for structural heart therapies and challenging current treatment options to change the course of patient care.1
IMAGING EXPERTISE
As transcatheter valve…
TRIFECTA™ GT
SURGICAL REPLACEMENT AORTIC VALVE
The Trifecta™ valve with Glide™ Technology (GT) and Linx™ anticalcification technology* was designed to offer excellent performance in 3 key…
PATIENTS WHO BENEFIT FROM PFO CLOSURE
The Amplatzer™ Talisman™ PFO Occluder is indicated for percutaneous transcatheter closure of a patent foramen ovale (PFO) to reduce the risk of recurrent…
AFib and STROKE RISK
with the Amplatzer™ Amulet™ LAA Occluder is an atrial fibrillation treatment that completely closes the left atrial appendage (LAA) and immediately eliminates the need for blood thinners.…
MAT-2104943 v2.0 | Item approved for U.S. use only.
Living with Your New Mechanical Heart Valve
READ MORE
Remote INR Monitoring Post Mechanical Heart Valve Procedures
READ MORE
What You Need to Know About Epic™ Valve Therapy
READ MORE
…
Aortic Stenosis
WHAT ARE THE SYMPTOMS OF AORTIC STENOSIS?
Aortic stenosis symptoms may not be noticeable during the mild-to-moderate stages of the disease when blood flow is not significantly reduced. As damage to…
Congenital Heart Disease
Aortic valve stenosis is a narrowed aortic valve. A valve with stenosis cannot open as much as it should to allow for blood flow. Stenosis makes the left ventricle pump harder to get blood through…
